Comparison of fasting glucose with post-load glucose values and glycated hemoglobin for prediction of type 2 diabetes: The Isfahan Diabetes Prevention Study

Review of Diabetic Studies

Volumn 6, Issue 2, 2009, Pages 117-123

  Janghorbani, Mohsen ^a,b   Amini, Masoud ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Fasting plasma glucose; First degree relatives; IFG; IGT; Impaired glucose tolerance; MetS; OGTT Hba1c; Post load plasma glucose; Type 2 diabetes

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; RELATIVE;

EID: 70349659871     PISSN: 16136071     EISSN: 16140575     Source Type: Journal    
DOI: 10.1900/RDS.2009.6.117     Document Type: Article

References (31)

1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003. 26(Suppl 1): S5-S20.
2. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002. 19(9):708-723. (Pubitemid 35013848)
3. Larsson H, Berglund G, Lindgärde F, Ahren B. Comparison of ADA and WHO criteria for diagnosis of diabetes and glucose intolerance. Diabetologia 1998. 41(9):1124-1125. (Pubitemid 28394421)
4. de Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA 2001. 285(16):2109-2113. (Pubitemid 32367828)
5. Shaw JE, Zimmet PZ, de Courten M, Dowse GK, Chitson P, Gareeboo H, Hemraj F, Fareed D, Tuomilehto J, Alberti KG. Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? Diabetes Care 1999. 22(3):399-402.
6. Vaccaro O, Ruffa G, Imperatore G, Iovino V, Rivellese AA, Riccardi G. Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis. Diabetes Care 1999. 22(9):1490-1493. (Pubitemid 29418244)
7. Qiao Q, Lindström J, Valle TT, Tuomilehto J. Progression to clinically diagnosed and treated diabetes from impaired glucose tolerance and impaired fasting glycaemia. Diabet Med 2003. 20(12):1027-1033 (Pubitemid 41701485)
8. Amini M, Janghorbani M. Diabetes and impaired glucose regulation in first-degree relatives of patients with type 2 diabetes in Isfahan, Iran: prevalence and risk factors. Rev Diabet Stud 2007. 4(3):169-176.
9. Nakagami T, DECODA Study Group. Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia 2004. 47(3):385-394. (Pubitemid 38491233)
10. Janus ED, Watt NM, Lam KS, Cockram CS, Siu ST, Liu LJ, Lam TH. The prevalence of diabetes, association with cardiovascular risk factors and implications of diagnostic criteria (ADA 1997 and WHO 1998) in a 1996 community-based population study in Hong Kong Chinese. Diabet Med 2000. 17(10):741-745.
11. Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2006. 29(5):1130-1139. (Pubitemid 44115261)
12. Abdul-Ghani MA, Lyssenko V, Tuomi T, DeFronzo RA, Groop L. Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study. Diabetes Care 2009. 32(2):281-286.
13. Executive summary. Standard of Medical Care in Diabetes-2008. Diabetes Care 2008. 31(Suppl 1):S5-S11.
14. Davidson MB, Schriger DL, Lorber B. HbA(1c) measurements do not improve the detection of type 2 diabetes in a randomly selected population. Diabetes Care 2001. 24(11):2017-2018.
15. Perry RC, Shankar RR, Fineberg N, McGill J, Baron AD. HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP). Diabetes Care 2001. 24(3):465-471. (Pubitemid 32198414)
16. Abdul-Ghani MA, Matsuda M, Sabbah M, Sabbah M, Jenkinson C, Richardson D, Kaku K, DeFronzo TA. The relative contributions of insulin resistance and beta cell failure to the transition from normal to impaired glucose tolerance vary in different ethnic groups. Diabetes Metab Syndr Clin Res Rev 2007. 1:105-112. (Pubitemid 46672917)
17. Genuth S, Alberti KG, Bennett P, Buse J, DeFronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003. 26(11):3160-3167. (Pubitemid 37339514)
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972. 18(6):499-502.
19. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001. 285(19):2486-2497.
20. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988. 44(3):837-845.
21. Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M. What is the best predictor of future type 2 diabetes? Diabetes Care 2007. 30:1544-1548.
22. Tsuji I, Nakamoto K, Hasegawa T, Hisashige A, Inawashiro H, Fukao A, Hisamichi S. Receiver operating characteristic analysis on fasting plasma glucose, HbA1c, and fructosamine on diabetes screening. Diabetes Care 1991. 14(11):1075-1077.
23. Ko GT, Chan JC, Tsang LW, Cockram CS. Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects. Diabetes Care 2000. 23(12):1770-1773.
24. Takahashi M, Kaji K, Togashi A, Onigo Y, Shibosawa T, Kawazu S. Usefulness of paired estimation of fasting plasma glucose and HbA1c; a long-term follow-up study of screened non-diabetic subjects. J Japan Diabet Soc 2001. 44:745-750.
25. Inoue K, Matsumoto M, Akimoto K. Fasting plasma glucose and HbA1c as risk factors for type 2 diabetes. Diabet Med 2008. 25(10):1157-1163.
26. Rothman DL, Magnusson I, Katz LD, Shulman RG, Shulman GI. Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. Science 1991. 254(5031):573-576. (Pubitemid 21917377)
27. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B, American Diabetes Association. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007. 30(3):753-759. (Pubitemid 46354366)
28. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002. 346(6):393-403.
29. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001. 344(18):1343-1350.
30. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997. 20(4):537-544.
31. Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, Li H, Li H, Jiang Y, An Y, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008. 371(9626):1783-1789.